UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Thrombosis and thrombocytopenia after HPV vaccination

Journal of thrombosis and haemostasis, 2022-03, Vol.20 (3), p.700-704

2022

Volltextzugriff (PDF)

Preclinical characterisation and development of a novel myelodysplastic syndrome‐derived cell line

British journal of haematology, 2021-04, Vol.193 (2), p.415-419

2021

Volltextzugriff (PDF)

Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation

Journal for immunotherapy of cancer, 2020-09, Vol.8 (2), p.e001223

2020

Volltextzugriff (PDF)

Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?

Current cancer drug targets, 2013, Vol.13 (1), p.30

2013

Volltextzugriff (PDF)

Targeting Immune Signaling Pathways in Clonal Hematopoiesis

Current medicinal chemistry, 2019-01, Vol.26 (28), p.5262

2019

Volltextzugriff (PDF)

Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications

BioMed research international, 2011-01, Vol.2011 (1), p.104631

2011

Volltextzugriff (PDF)

The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes

International journal of molecular sciences, 2016-07, Vol.17 (7), p.1080-1080

2016

Volltextzugriff (PDF)

A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae

Biology open, 2022-12, Vol.11 (12)

2022

Volltextzugriff (PDF)

Myeloid‐Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets

HemaSphere, 2019-02, Vol.3 (1), p.e168-n/a

2019

Volltextzugriff (PDF)

Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release

Expert opinion on investigational drugs, 2010-02, Vol.19 (2), p.169-183

2010

Volltextzugriff (PDF)

High-dose etoposide in allogeneic stem cell transplantation

Cancer chemotherapy and pharmacology, 2012-12, Vol.70 (6), p.765-782

2012

Volltextzugriff (PDF)

The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity

Toxins, 2010-01, Vol.2 (1), p.174-194

2010

Volltextzugriff (PDF)

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome

Oncoimmunology, 2016-02, Vol.5 (2), p.e1062208-e1062208

2016

Volltextzugriff (PDF)

Monitorering av ufraksjonert heparin

Tidsskrift for den Norske Lægeforening, 2022

2022

Volltextzugriff (PDF)

Monitoring of unfractionated heparin

Tidsskrift for den Norske Lægeforening, 2022-03, Vol.142 (5)

2022

Volltextzugriff (PDF)

The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation

Toxins, 2013-02, Vol.5 (2), p.336-362

2013

Volltextzugriff (PDF)

Analysis of anti-leukemic activity, predictive biomarker candidates, immune activation and pharmakodynamics in R/R AML and MDS in response to treatment with bemcentinib (BGB324), a first-in class selective AXL inhibitor, in a phase II open-label, multi-centre study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.7020-7020

2018

Volltextzugriff (PDF)

The chemokine system in experimental and clinical hematology

Current topics in microbiology and immunology, 2010, Vol.341, p.3

2010

Volltextzugriff (PDF)

Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes

Cancer Immunology, Immunotherapy, 2016-09, Vol.65 (9), p.1135-1147

2016

Volltextzugriff (PDF)

A 35-year-old woman with influenza A-associated thrombotic thrombocytopenic purpura

Blood coagulation & fibrinolysis, 2015-06, Vol.26 (4), p.469-472

2015

Volltextzugriff (PDF)

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia

Clinical epigenetics, 2013-08, Vol.5 (1), p.13-13, Article 13

2013

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population

Transplantation and cellular therapy, 2021-12, Vol.27 (12), p.991.e1-991.e9

2021

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(17)
Oncology
(9)
Hematology
(8)
Immunology
(7)
Acute Myeloid Leukemia
(6)
Female
(6)
Animals
(5)
Leukemia
(5)
Medicin Och Hälsovetenskap
(5)
Myelodysplastic Syndrome
(5)
Allogeneic Stem Cell Transplantation
(4)
Leukemia, Myeloid, Acute - Therapy
(4)
Male
(4)
Myelodysplastic Syndromes
(4)
Review
(4)
Transplantation, Homologous
(4)
Adult
(3)
Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thrombosis and thrombocytopenia after HPV vaccination

Preclinical characterisation and development of a novel myelodysplastic syndrome‐derived cell line

Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation

Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?

Targeting Immune Signaling Pathways in Clonal Hematopoiesis

Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow‐up

The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes

A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae

Myeloid‐Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets

Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release

High-dose etoposide in allogeneic stem cell transplantation

The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome

Monitorering av ufraksjonert heparin

"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"

Monitoring of unfractionated heparin

Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B

The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation

Analysis of anti-leukemic activity, predictive biomarker candidates, immune activation and pharmakodynamics in R/R AML and MDS in response to treatment with bemcentinib (BGB324), a first-in class selective AXL inhibitor, in a phase II open-label, multi-centre study

The chemokine system in experimental and clinical hematology

Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes

A 35-year-old woman with influenza A-associated thrombotic thrombocytopenic purpura

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population

Suchergebnisse filtern